COMP <GO>
ONC vs ZTS // OPERATING MARGIN
BeOne Medicines Ltd. (NASDAQ) VS. Zoetis Inc. (NYSE) • 15-METRIC TALLY: ONC 5
— ZTS 8
▲ OPERATING MARGIN LEADER: ZTS
LAST: $361.27 (-2.45%) • MKT CAP: $42.11B
operating-margins
8.40%
LAST: $83.18 (+4.34%) • MKT CAP: $32.94B
operating-margins
34.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ONC VS. ZTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ONC | ZTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.50% | 71.80% | +15.70 | ONC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.50% | 25.70% | -15.20 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 63.9x | 10.3x | +53.60 | ZTS | /valuation <GO> |
| Free Cash Flow Yield | 2.23% | 7.01% | -4.78 | ZTS | /fcf-yield <GO> |
| Operating Margin ACTIVE | 8.40% | 34.40% | -26.00 | ZTS | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 28.20% | -22.80 | ZTS | /net-margins <GO> |
| Revenue Growth (YoY) | 40.20% | 2.30% | +37.90 | ONC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.68 | 4.53 | +2.15 | ONC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ONC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.4 | 59.6 | -7.20 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.99 | -0.01 | ZTS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 123.6x | 11.3x | +112.30 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $42.11B | $32.94B | $9.17B | ONC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ONC REV | ZTS REV | ONC GROSS % | ZTS GROSS % | ONC FCF | ZTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.34B | $9.47B | 87.5% | 71.8% | $941.7M | $2.28B |
| FY 2024 | $3.81B | $9.26B | 84.4% | 70.6% | -$633.3M | $2.30B |
| FY 2023 | $2.46B | $8.54B | — | — | -$1.27B | $1.97B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ONC // BETA 0.98
ZTS // BETA 0.99